| Trial ID: | L7215 |
| Source ID: | NCT03011177
|
| Associated Drug: |
Teneligliptin
|
| Title: |
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
|
| Acronym: |
TELIUS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes Mellitus
|
| Interventions: |
DRUG: Teneligliptin|DRUG: Linagliptin
|
| Outcome Measures: |
Primary: HbA1c, 12week |
|
| Sponsor/Collaborators: |
Sponsor: Handok Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
168
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-01
|
| Completion Date: |
2018-09
|
| Results First Posted: |
|
| Last Update Posted: |
2019-02-22
|
| Locations: |
Asan Medical Center, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03011177
|
